Ayse Gungor,Raymond P Najjar,Steffen Hamann,Zhiqun Tang,Wolf A Lagrèze,Riccardo Sadun,Kanchalika Sathianvichitr,Marc J Dinkin,Cristiano Oliveira,Anfei Li,Federico Sadun,Andrew R Carey,Walid Bouthour,Mung Yan Lin,Jing-Liang Loo,Neil R Miller,Nancy J Newman,Valérie Biousse,Dan Milea,BONSAI Group,Axel Petzold,Philippe Gohier,Ajay Patil,Tanyatuth Padungkiatsagul,Yanin Suwan,Kavin Vanikieti,Piero Barboni,Valerio Carelli,Chiara La Morgia,Marie-Bénédicte Rougier,Fiona Costello,Étienne Bénard-Séguin,Leonard B Milea,Selvakumar Ambika,Pedro Fonseca,Michael S Hansen,Sebastian Küchlin,Navid Farassat,Nicolae Sanda,Gabriele Thumann,Christophe Chiquet,Hui Yang,Carol Y Cheung,Carmen Km Chan,Makoto Nakamura,Takano Fumio,Thi Hc Tran,Neringa Jurkute,Patrick Yu-Wai-Man,Richard Kho,Jost B Jonas,Luis J Mejico,Catherine Clermont-Vignal,Raoul K Khanna,Cedric Lamirel,Valérie Touitou,John J Chen,Jeong-Min Hwang,Hee K Yang,Dong H Kim,Tin Aung,Ecosse Lamoureux,Leopold Schmetterer,Christine Yw Leng,Michael Ja Girard,Clare L Fraser,Masoud A Fard,Jonathan A Micieli

Abstract:Importance: Prompt and accurate diagnosis of arteritic anterior ischemic optic neuropathy (AAION) from giant cell arteritis and other systemic vasculitis can contribute to preventing irreversible vision loss from these conditions. Its clinical distinction from nonarteritic anterior ischemic optic neuropathy (NAION) can be challenging, especially when systemic symptoms are lacking or laboratory markers of the disease are not reliable. Objective: To develop, train, and test a deep learning system (DLS) to discriminate AAION from NAION on color fundus images during the acute phase. Design, setting, and participants: This was an international study including color fundus images of 961 eyes of 802 patients with confirmed AAION and NAION. Training was performed using images from 21 expert neuro-ophthalmology centers in 16 countries, while external testing was performed in a cohort from 5 expert neuro-ophthalmology centers in the US and Europe. Data for training and external testing were collected from August 2018 to January 2023. A mix of deidentified images of 2 fields of view (optic disc centered and macula centered) were used. For training and internal validation, images were from 16 fundus camera models with fields of 30° to 55°. For external testing, images were from 5 fundus cameras with fields of 30° to 50°. Data were analyzed from January 2023 to January 2024. Main outcomes and measures: The performance of the DLS was measured using area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy. Results: In the training and validation sets, 374 (54.9%) of patients were female, 301 (44.2%) were male, and 6 (0.9%) were of unknown sex; the median (range) age was 66 (23-96) years. When tested on the external dataset including 121 patients (35 [28.9%] female, 44 [36.4%] male, and 42 [34.7%] of unknown sex; median [range] age, 69 [37-89] years), the DLS achieved an AUC of 0.97 (95% CI, 0.95-0.99), a sensitivity of 91.1% (95% CI, 85.2-96.9), a specificity of 93.4% (95% CI, 91.1-98.2), and an accuracy of 92.6% (95% CI, 90.5-96.6). The accuracy of the 2 experts for classification of the same dataset was 74.3% (95% CI, 66.7-81.9) and 81.6% (95% CI, 74.8-88.4), respectively. Conclusions and relevance: A DLS showing disease-specific averaged class-activation maps had greater than 90% accuracy at discriminating between acute AAION from NAION on color fundus images, at the eye level, without any clinical or biomarker information. A DLS that identifies AAION could improve clinical decision-making, potentially reducing the risk of misdiagnosis and improving patient outcomes.

Optic Disc Classification by Deep Learning versus Expert Neuro‐Ophthalmologists

A Deep Learning Approach for Accurate Discrimination Between Optic Disc Drusen and Papilledema on Fundus Photographs

The BONSAI (Brain and Optic Nerve Study with Artificial Intelligence) deep learning system can accurately identify pediatric papilledema on standard ocular fundus photographs

Deep learning-based optic disc classification is affected by optic-disc tilt

A Deep Learning-Based Algorithm Identifies Glaucomatous Discs Using Monoscopic Fundus Photographs

Artificial intelligence and neuro‐ophthalmology

Deep Learning and Glaucoma Specialists: The Relative Importance of Optic Disc Features to Predict Glaucoma Referral in Fundus Photos

An Artificial-Intelligence- and Telemedicine-Based Screening Tool to Identify Glaucoma Suspects from Color Fundus Imaging

Deep Learning for Optic Disc Segmentation and Glaucoma Diagnosis on Retinal Images

Evaluation of an AI system for the automated detection of glaucoma from stereoscopic optic disc photographs: the European Optic Disc Assessment Study

Deep Learning to Discriminate Arteritic From Nonarteritic Ischemic Optic Neuropathy on Color Images

From Machine to Machine: An OCT-trained Deep Learning Algorithm for Objective Quantification of Glaucomatous Damage in Fundus Photographs

Generalizability of Deep Neural Networks for Vertical Cup-to-Disc Ratio Estimation in Ultra-Widefield and Smartphone-Based Fundus Images

Assessing the Efficacy of Synthetic Optic Disc Images for Detecting Glaucomatous Optic Neuropathy Using Deep Learning

Development of a deep learning model to distinguish the cause of optic disc atrophy using retinal fundus photography

Automated segmentation of the optic disc from fundus images using an asymmetric deep learning network

Development and validation of a deep learning system to screen vision-threatening conditions in high myopia using optical coherence tomography images

Application of a deep learning system in glaucoma screening and further classification with colour fundus photographs: a case control study

Deep Learning Evaluation of Glaucoma Detection Using Fundus Photographs in Highly Myopic Populations

Retinal photograph-based deep learning algorithms for myopia and a blockchain platform to facilitate artificial intelligence medical research: a retrospective multicohort study

Evaluation of a novel deep learning based screening system for pathologic myopia.